The Italian society of rheumatology clinical practice guidelines for the diagnosis and management of gout

Nicola Ughi, I. Prevete, R. Ramonda, L. Cavagna, G. Filippou, M. Manara, A. Bortoluzzi, S. Parisi, A. Ariani, C. A. Scirè

Research output: Contribution to journalReview article

Abstract

Gout is a chronic disease with an increased risk of premature death related to comorbidities. Treatment of gout has proved suboptimal and clinical practice guidelines (CPGs) are expected to have a key role in achieving improvement. Since new evidence has become available, the Italian Society for Rheumatology (SIR) has been prompted to update the 2013 recommendations on the diagnosis and management of gout. The framework of the Guidelines International Network Adaptation Working Group was adopted to identify, appraise (AGREE II), synthesize, and customize the existing gout CPGs to the needs of the Italian healthcare context. The task force consisting of rheumatologists from the SIR Epidemiology Unit and a committee with experience on gout identified key health questions to guide a systematic literature review. The target audience includes physicians and health professionals who manage gout in practice, and the target population includes adult patients suspected or diagnosed as having gout. These recommendations were finally rated by an external multi-disciplinary commission. From a systematic search in databases (Medline, Embase) and grey literature, 8 CPGs were selected and appraised by two independent raters. Combining evidence and statements from these CPGs and clinical expertise, 14 recommendations were developed and graded according to the level of evidence. The statements and potential impact on clinical practice were discussed and assessed. These revised recommendations are intended to provide guidance for the diagnosis and the treatment of gout and to disseminate the best evidence-based healthcare for this disease.

Original languageEnglish
Pages (from-to)50-79
Number of pages30
JournalReumatismo
Volume71
Issue numberS1
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Gout
Practice Management
Rheumatology
Practice Guidelines
Literature
Premature Mortality
Health Services Needs and Demand
Evidence-Based Practice
Health
Advisory Committees
Comorbidity
Epidemiology
Chronic Disease
Databases
Guidelines
Delivery of Health Care
Physicians
Therapeutics

Keywords

  • Clinical practice guideline
  • Diagnosis
  • Gout
  • Recommendations
  • Treatment

ASJC Scopus subject areas

  • Rheumatology

Cite this

The Italian society of rheumatology clinical practice guidelines for the diagnosis and management of gout. / Ughi, Nicola; Prevete, I.; Ramonda, R.; Cavagna, L.; Filippou, G.; Manara, M.; Bortoluzzi, A.; Parisi, S.; Ariani, A.; Scirè, C. A.

In: Reumatismo, Vol. 71, No. S1, 01.01.2019, p. 50-79.

Research output: Contribution to journalReview article

Ughi, Nicola ; Prevete, I. ; Ramonda, R. ; Cavagna, L. ; Filippou, G. ; Manara, M. ; Bortoluzzi, A. ; Parisi, S. ; Ariani, A. ; Scirè, C. A. / The Italian society of rheumatology clinical practice guidelines for the diagnosis and management of gout. In: Reumatismo. 2019 ; Vol. 71, No. S1. pp. 50-79.
@article{a25169e52c2c4ce38a9695657c7831a4,
title = "The Italian society of rheumatology clinical practice guidelines for the diagnosis and management of gout",
abstract = "Gout is a chronic disease with an increased risk of premature death related to comorbidities. Treatment of gout has proved suboptimal and clinical practice guidelines (CPGs) are expected to have a key role in achieving improvement. Since new evidence has become available, the Italian Society for Rheumatology (SIR) has been prompted to update the 2013 recommendations on the diagnosis and management of gout. The framework of the Guidelines International Network Adaptation Working Group was adopted to identify, appraise (AGREE II), synthesize, and customize the existing gout CPGs to the needs of the Italian healthcare context. The task force consisting of rheumatologists from the SIR Epidemiology Unit and a committee with experience on gout identified key health questions to guide a systematic literature review. The target audience includes physicians and health professionals who manage gout in practice, and the target population includes adult patients suspected or diagnosed as having gout. These recommendations were finally rated by an external multi-disciplinary commission. From a systematic search in databases (Medline, Embase) and grey literature, 8 CPGs were selected and appraised by two independent raters. Combining evidence and statements from these CPGs and clinical expertise, 14 recommendations were developed and graded according to the level of evidence. The statements and potential impact on clinical practice were discussed and assessed. These revised recommendations are intended to provide guidance for the diagnosis and the treatment of gout and to disseminate the best evidence-based healthcare for this disease.",
keywords = "Clinical practice guideline, Diagnosis, Gout, Recommendations, Treatment",
author = "Nicola Ughi and I. Prevete and R. Ramonda and L. Cavagna and G. Filippou and M. Manara and A. Bortoluzzi and S. Parisi and A. Ariani and Scir{\`e}, {C. A.}",
year = "2019",
month = "1",
day = "1",
doi = "10.4081/reumatismo.2019.1176",
language = "English",
volume = "71",
pages = "50--79",
journal = "Reumatismo",
issn = "0048-7449",
publisher = "PAGEPRESS PUBL",
number = "S1",

}

TY - JOUR

T1 - The Italian society of rheumatology clinical practice guidelines for the diagnosis and management of gout

AU - Ughi, Nicola

AU - Prevete, I.

AU - Ramonda, R.

AU - Cavagna, L.

AU - Filippou, G.

AU - Manara, M.

AU - Bortoluzzi, A.

AU - Parisi, S.

AU - Ariani, A.

AU - Scirè, C. A.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Gout is a chronic disease with an increased risk of premature death related to comorbidities. Treatment of gout has proved suboptimal and clinical practice guidelines (CPGs) are expected to have a key role in achieving improvement. Since new evidence has become available, the Italian Society for Rheumatology (SIR) has been prompted to update the 2013 recommendations on the diagnosis and management of gout. The framework of the Guidelines International Network Adaptation Working Group was adopted to identify, appraise (AGREE II), synthesize, and customize the existing gout CPGs to the needs of the Italian healthcare context. The task force consisting of rheumatologists from the SIR Epidemiology Unit and a committee with experience on gout identified key health questions to guide a systematic literature review. The target audience includes physicians and health professionals who manage gout in practice, and the target population includes adult patients suspected or diagnosed as having gout. These recommendations were finally rated by an external multi-disciplinary commission. From a systematic search in databases (Medline, Embase) and grey literature, 8 CPGs were selected and appraised by two independent raters. Combining evidence and statements from these CPGs and clinical expertise, 14 recommendations were developed and graded according to the level of evidence. The statements and potential impact on clinical practice were discussed and assessed. These revised recommendations are intended to provide guidance for the diagnosis and the treatment of gout and to disseminate the best evidence-based healthcare for this disease.

AB - Gout is a chronic disease with an increased risk of premature death related to comorbidities. Treatment of gout has proved suboptimal and clinical practice guidelines (CPGs) are expected to have a key role in achieving improvement. Since new evidence has become available, the Italian Society for Rheumatology (SIR) has been prompted to update the 2013 recommendations on the diagnosis and management of gout. The framework of the Guidelines International Network Adaptation Working Group was adopted to identify, appraise (AGREE II), synthesize, and customize the existing gout CPGs to the needs of the Italian healthcare context. The task force consisting of rheumatologists from the SIR Epidemiology Unit and a committee with experience on gout identified key health questions to guide a systematic literature review. The target audience includes physicians and health professionals who manage gout in practice, and the target population includes adult patients suspected or diagnosed as having gout. These recommendations were finally rated by an external multi-disciplinary commission. From a systematic search in databases (Medline, Embase) and grey literature, 8 CPGs were selected and appraised by two independent raters. Combining evidence and statements from these CPGs and clinical expertise, 14 recommendations were developed and graded according to the level of evidence. The statements and potential impact on clinical practice were discussed and assessed. These revised recommendations are intended to provide guidance for the diagnosis and the treatment of gout and to disseminate the best evidence-based healthcare for this disease.

KW - Clinical practice guideline

KW - Diagnosis

KW - Gout

KW - Recommendations

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85073610974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073610974&partnerID=8YFLogxK

U2 - 10.4081/reumatismo.2019.1176

DO - 10.4081/reumatismo.2019.1176

M3 - Review article

AN - SCOPUS:85073610974

VL - 71

SP - 50

EP - 79

JO - Reumatismo

JF - Reumatismo

SN - 0048-7449

IS - S1

ER -